Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -2.114\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CCOc1ccc(S(=O)(=O)N2CCCC(C(=O)NCC3CCCO3)C2)cc1Cl
[b] COC(=O)c1c(NC(=O)CSc2nnnn2-c2ccccc2)sc2c1CCCC2
Answer: b. COC(=O)c1c(NC(=O)CSc2nnnn2-c2ccccc2)sc2c1CCCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1c(NC(=O)CSc2nnnn2-c2ccccc2)sc2c1CCCC2
COC(=O)c1c(NC(=O)CSc2nnnn2-c2ccccc2)sc2c1CCCC2
methyl2-[[2-(1-phenyltetrazol-5-yl)sulfanylacetyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate